Honz Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Honz Pharmaceutical has a total shareholder equity of CN¥1.3B and total debt of CN¥529.5M, which brings its debt-to-equity ratio to 39.6%. Its total assets and total liabilities are CN¥2.1B and CN¥794.7M respectively. Honz Pharmaceutical's EBIT is CN¥2.9M making its interest coverage ratio 0.1. It has cash and short-term investments of CN¥114.3M.
Key information
39.6%
Debt to equity ratio
CN¥529.47m
Debt
| Interest coverage ratio | 0.1x |
| Cash | CN¥114.29m |
| Equity | CN¥1.34b |
| Total liabilities | CN¥794.66m |
| Total assets | CN¥2.13b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300086's short term assets (CN¥569.1M) exceed its short term liabilities (CN¥391.1M).
Long Term Liabilities: 300086's short term assets (CN¥569.1M) exceed its long term liabilities (CN¥403.6M).
Debt to Equity History and Analysis
Debt Level: 300086's net debt to equity ratio (31.1%) is considered satisfactory.
Reducing Debt: 300086's debt to equity ratio has increased from 12.3% to 39.6% over the past 5 years.
Debt Coverage: 300086's debt is not well covered by operating cash flow (12.4%).
Interest Coverage: 300086's interest payments on its debt are not well covered by EBIT (0.1x coverage).